Literature DB >> 33834413

Creative, Person-Centered Narrative Psychopharmacotherapy of Depression.

Miro Jakovljevic1.   

Abstract

Depression as a multifactorial, polygenic mental disorder with thousands faces, poorly defined endophenotypes and characterized with high rate of morbidity, comorbidity, disability, mortality, and treatment failures, remains a relentless illness with heavy burden on patients, their families, and society. Therapeutic outcome of depression needs to be significantly improved and overcome the 65% barrier. The best treatments are those that utilize and integrate multiple modalities. The time is ripe for psychiatry to find its transdisciplinary integrative soul and increase treatment effectiveness. Creation and fostering hope, meaning, personal responsibility, spirit of optimism, and commitment can significantly contribute to overall positive response to pharmacotherapy, but in the other way round drug treatment can also contribute to creation and fostering hope, meaning, personal responsibility, spirit of optimism, and commitment. This chapter addresses the concept of creative person-centered narrative psychopharmacotherapy (CP-CNP) as a transdisciplinary integrative strategy for improvement of the therapeutic effectiveness in patients with depression.

Entities:  

Keywords:  Creative psychopharmacotherapy; Depression; Person-centered narrative medicine; Personal recovery; Resilience

Mesh:

Year:  2021        PMID: 33834413     DOI: 10.1007/978-981-33-6044-0_23

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  16 in total

Review 1.  Depression: a diagnosis aptly used?

Authors:  Johannes Wancata; Fabian Friedrich
Journal:  Psychiatr Danub       Date:  2011-12       Impact factor: 1.063

Review 2.  Depression and adult neurogenesis: Positive effects of the antidepressant fluoxetine and of physical exercise.

Authors:  Laura Micheli; Manuela Ceccarelli; Giorgio D'Andrea; Felice Tirone
Journal:  Brain Res Bull       Date:  2018-09-17       Impact factor: 4.077

3.  Neuroprotective Benefits of Antidepressants in Multiple Sclerosis: Are We Missing the Mark?

Authors:  Lisa B Grech; Ernest Butler; Stephen Stuckey; Robert Hester
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2019-04-03       Impact factor: 2.198

4.  Hypothalamic-pituitary-adrenal axis function and platelet serotonin concentrations in depressed patients.

Authors:  N Pivac; M Jakovljević; D Mück-Seler; Z Brzović
Journal:  Psychiatry Res       Date:  1997-12-05       Impact factor: 3.222

5.  Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems.

Authors:  Asli Sarandol; Emre Sarandol; Salih Saygin Eker; Selda Erdinc; Ebru Vatansever; Selcuk Kirli
Journal:  Hum Psychopharmacol       Date:  2007-03       Impact factor: 1.672

Review 6.  Creativity, mental disorders and their treatment: recovery-oriented psychopharmacotherapy.

Authors:  Miro Jakovljević
Journal:  Psychiatr Danub       Date:  2013-09       Impact factor: 1.063

7.  Myths and facts in contemporary psychopharmacotherapy: evidence-based vs. evidence-biased treatment algorithms practice.

Authors:  Miro Jakovljević
Journal:  Psychiatr Danub       Date:  2007-12       Impact factor: 1.063

Review 8.  Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.

Authors:  Andrea Cipriani; Toshi A Furukawa; Georgia Salanti; Anna Chaimani; Lauren Z Atkinson; Yusuke Ogawa; Stefan Leucht; Henricus G Ruhe; Erick H Turner; Julian P T Higgins; Matthias Egger; Nozomi Takeshima; Yu Hayasaka; Hissei Imai; Kiyomi Shinohara; Aran Tajika; John P A Ioannidis; John R Geddes
Journal:  Lancet       Date:  2018-02-21       Impact factor: 79.321

9.  Clinical Practice Guidelines for the management of Depression.

Authors:  Shiv Gautam; Akhilesh Jain; Manaswi Gautam; Vihang N Vahia; Sandeep Grover
Journal:  Indian J Psychiatry       Date:  2017-01       Impact factor: 1.759

Review 10.  Depressive disorders: Treatment failures and poor prognosis over the last 50 years.

Authors:  Thomas P Blackburn
Journal:  Pharmacol Res Perspect       Date:  2019-05-03
View more
  1 in total

1.  Cang-Ai Volatile Oil Ameliorates Depressive Behavior Induced by Chronic Stress Through IDO-Mediated Tryptophan Degradation Pathway.

Authors:  Kailing Zhang; Na Lei; Meng Li; Jijun Li; Caijun Li; Yue Shen; Peixin Guo; Lei Xiong; Yuhuan Xie
Journal:  Front Psychiatry       Date:  2021-12-15       Impact factor: 4.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.